Too Few Girls Getting HPV Vaccine: CDC

Lagging rates will lead to more cervical cancer cases, health officials contend

HealthDay SHARE

"We don't think cost is a barrier, and it's not showing up as a main concern in our survey," said Dr. Anne Schuchat, director of the CDC's National Center for Immunization and Respiratory Diseases. "That's one of the responses they may offer, but we're not seeing it."

The HPV vaccine has a strong track record of safety, the CDC said.

About 56 million doses of Gardasil, the more popular HPV vaccine, were distributed in the United States from June 2006 through March 2013, according to the report. Those doses have resulted in just 21,194 reports of adverse reactions to the vaccine, with 92 percent classified as nonserious side effects. Reports of adverse reactions have steadily declined since 2009.

More information

For more information on the HPV vaccine, visit the U.S. Centers for Disease Control and Prevention.

Copyright © 2012 HealthDay. All rights reserved.